Markus Hartenbach

2.3k total citations · 1 hit paper
36 papers, 1.2k citations indexed

About

Markus Hartenbach is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Markus Hartenbach has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Radiology, Nuclear Medicine and Imaging, 23 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Markus Hartenbach's work include Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Medical Imaging Techniques and Applications (14 papers). Markus Hartenbach is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Medical Imaging Techniques and Applications (14 papers). Markus Hartenbach collaborates with scholars based in Austria, United States and Germany. Markus Hartenbach's co-authors include Marcus Hacker, Wolfgang Wadsak, Alexander Haug, Ken Herrmann, Boris Hadaschik, Robert E. Reiter, Wolfgang P. Fendler, Thomas A. Hope, Tobias Maurer and Matthias Eiber and has published in prestigious journals such as NeuroImage, Clinical Cancer Research and Theranostics.

In The Last Decade

Markus Hartenbach

33 papers receiving 1.2k citations

Hit Papers

Prostate Cancer Molecular Imaging Standardized Evaluation... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Hartenbach Austria 18 906 844 160 126 97 36 1.2k
Tom Claeys Belgium 11 1.1k 1.2× 526 0.6× 302 1.9× 158 1.3× 131 1.4× 29 1.4k
Hiromitsu Daisaki Japan 15 337 0.4× 692 0.8× 138 0.9× 82 0.7× 30 0.3× 57 945
J. Pruim Netherlands 13 580 0.6× 361 0.4× 153 1.0× 57 0.5× 95 1.0× 20 922
Francesco Cicone Italy 20 762 0.8× 739 0.9× 312 1.9× 52 0.4× 22 0.2× 68 1.5k
Martin D. Pickles United Kingdom 18 588 0.6× 1.7k 2.0× 78 0.5× 176 1.4× 101 1.0× 23 1.9k
Thomas Pyka Germany 18 528 0.6× 896 1.1× 118 0.7× 101 0.8× 82 0.8× 30 1.2k
I. Brenot-Rossi France 16 310 0.3× 206 0.2× 185 1.2× 189 1.5× 110 1.1× 39 924
Tomáš Kazda Czechia 16 388 0.4× 259 0.3× 222 1.4× 189 1.5× 48 0.5× 101 1000
Courtney Lawhn-Heath United States 15 296 0.3× 282 0.3× 140 0.9× 63 0.5× 32 0.3× 38 579
Mathias J. Zacherl Germany 13 282 0.3× 348 0.4× 196 1.2× 45 0.4× 28 0.3× 54 682

Countries citing papers authored by Markus Hartenbach

Since Specialization
Citations

This map shows the geographic impact of Markus Hartenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hartenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hartenbach more than expected).

Fields of papers citing papers by Markus Hartenbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hartenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hartenbach. The network helps show where Markus Hartenbach may publish in the future.

Co-authorship network of co-authors of Markus Hartenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Hartenbach. A scholar is included among the top collaborators of Markus Hartenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Hartenbach. Markus Hartenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mair, Maximilian J., Sabrina Hartenbach, Erwin Tomasich, et al.. (2025). Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma. European Journal of Nuclear Medicine and Molecular Imaging. 52(8). 2771–2781. 1 indexed citations
2.
Spielvogel, Clemens P., Jing Ning, László Papp, et al.. (2024). Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI. Insights into Imaging. 15(1). 299–299. 3 indexed citations
3.
Grubmüller, Bernhard, Nicolai Huebner, Sazan Rasul, et al.. (2023). Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer. Current Oncology. 30(2). 1683–1691. 1 indexed citations
4.
Rasul, Sazan, Markus Hartenbach, Tim Wollenweber, et al.. (2020). Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(5). 1650–1657. 27 indexed citations
5.
Rischka, Lucas, Gregor Gryglewski, Neydher Berroterán-Infante, et al.. (2019). Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI. Frontiers in Physiology. 10. 1422–1422. 3 indexed citations
6.
Haug, Alexander, Asha Leisser, Wolfgang Wadsak, et al.. (2019). Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [68Ga]Ga-Pentixafor-PET/MRI. Theranostics. 9(12). 3653–3658. 41 indexed citations
7.
Kimura, Shoji, Mohammad Abufaraj, Florian Janisch, et al.. (2019). Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 23(1). 1–10. 31 indexed citations
8.
Grubmüller, Bernhard, Gero Kramer, Pascal Baltzer, et al.. (2018). Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 46(5). 1063–1072. 114 indexed citations
9.
Rischka, Lucas, Gregor Gryglewski, Sarah Pfaff, et al.. (2018). Reduced task durations in functional PET imaging with [18F]FDG approaching that of functional MRI. NeuroImage. 181. 323–330. 45 indexed citations
10.
Rasul, Sazan, Sabrina Hartenbach, Georgios Karanikas, et al.. (2018). [18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery. European Journal of Nuclear Medicine and Molecular Imaging. 45(12). 2159–2169. 34 indexed citations
11.
Grubmüller, Bernhard, Pascal Baltzer, David D‘Andrea, et al.. (2017). 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making. European Journal of Nuclear Medicine and Molecular Imaging. 45(2). 235–242. 95 indexed citations
12.
Hahn, Andreas, Gregor Gryglewski, Lukas Nics, et al.. (2017). Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity. Brain Structure and Function. 223(3). 1369–1378. 30 indexed citations
13.
Rausch, Ivo, Petra Rust, Matthew D. DiFranco, et al.. (2016). Reproducibility of MRI Dixon-Based Attenuation Correction in Combined PET/MR with Applications for Lean Body Mass Estimation. Journal of Nuclear Medicine. 57(7). 1096–1101. 16 indexed citations
14.
Haug, Alexander, Wolfgang Wadsak, Markus Mitterhauser, et al.. (2016). Initial experience with aggressive treatment of metastastic prostate cancer using 3 cycles of 7.4 GBq [177Lu]-PSMA every 4 weeks. Endocrine Abstracts.
15.
Li, Xiang, Ivo Rausch, Dietrich Beitzke, et al.. (2016). Quantitative assessment of atherosclerotic plaques on 18F-FDG PET/MRI: comparison with a PET/CT hybrid system. European Journal of Nuclear Medicine and Molecular Imaging. 43(8). 1503–1512. 29 indexed citations
16.
Mayerhoefer, Marius E., Chiara Giraudo, Markus Hartenbach, et al.. (2015). Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?. Clinical Nuclear Medicine. 41(2). 101–105. 16 indexed citations
17.
Hartenbach, Markus, Sabrina Hartenbach, B. Danz, et al.. (2014). Combined PET/MRI Improves Diagnostic Accuracy in Patients with Prostate Cancer: A Prospective Diagnostic Trial. Clinical Cancer Research. 20(12). 3244–3253. 45 indexed citations
18.
Hartenbach, Markus, Andreas Delker, Sabrina Hartenbach, et al.. (2014). Dose-Dependent Uptake of 3′-deoxy-3′-[18 F]Fluorothymidine by the Bowel after Total-Body Irradiation. Molecular Imaging and Biology. 16(6). 846–853. 1 indexed citations
19.
Graute, Vera, Nathalie Jansen, Christopher Übleis, et al.. (2011). Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging. 39(2). 271–282. 62 indexed citations
20.
Niedermoser, Sabrina, Franz Josef Gildehaus, Carmen Wängler, et al.. (2011). Evaluation of an automated double-synthesis module: efficiency and reliability of subsequent radiosyntheses of FHBG and FLT. Nuclear Medicine and Biology. 39(4). 586–592. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026